Skip to main content
SpringerLink
Log in

Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death

  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Summary

The antifibrillatory, antithrombotic and hemodynamic properties of intraventricular prostacyclin (PGI2) application were studied in a conscious canine model of sudden cardiac death. In anesthetized dogs, a wire electrode was implanted into the left circumflex coronary artery (LCX) and acute myocardial ischemia was produced by 90 min occlusion of the left anterior descending coronary artery (LAD) followed by reperfusion. An intracardiac pressure transducer measured ventricular pressure, heart rate, filling pressure and dP/dt. The ECG was obtained from subcutaneous chest needles. Six days later while in ambulatory state, a 180 μA DC current was applied for 4 h to the LCX intimal lining in Tris-HCl (n=10) and PGI2-treated dogs (50 and 100 ng/kg/min, 11 and 12 dogs, respectively).

Myocardial injury and coronary thrombosis induced by electrical stimulation produced ventricular fibrillation in all vehicle-treated dogs at 145±33 min (mean±S.D.). In PGI2-treated hearts only 2 animals fibrillated at 150±29 min and 180±52 min following 50 and 100 ng/kg/min of the prostanoid, respectively. Thus, 18/23 PGI2-treated dogs survived 4h electrical stimulation of the artery.

Within the LAD perfusion zone infarction was observed of equal volumes in vehicle and PGI2-treated animals. No ischemia occurred distal to the LCX coronary thrombosis. Ventricular pressure fell in all groups. Heart rate increased in the controls and those animals treated with 50 ng/kg/min PGI2 while 100 ng/kg/min PGI2 increased heart rate by 22±5% (p<0.05). Filling pressure increased in controls but fell in the PGI2-treated hearts.

The results indicate that PGI2 can prevent ventricular fibrillation resulting from acute ischemia at a site distant to previous myocardial ischemia with superimposed intimal injury and coronary thrombosis. The PGI2 properties are due to prevention of coronary thrombosis and the occlusion of the artery. Antifibrillatory effects of the prostanoids are suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kannel WB, Thomas HR Jr (1982) Sudden coronary death: The Framingham study. Ann NY Acad Sci 382:3–21

    PubMed  Google Scholar 

  2. Schuster EH, Bulkley BH (1980) Ischemia at a distance after acute myocardial infarction: a cause of early postinfarction angina. Circulation 62:509–515

    PubMed  Google Scholar 

  3. Naccarella FF, Weintraub WS, Agarwal JB, Helfant RH (1984) Evaluation of “ischemia at a distance”: effects of coronary occlusion on a remote area of left ventricle. Am J Cardiol 54:869–874

    PubMed  Google Scholar 

  4. Friedman M, Manwaring JH, Rosenman RH, Donlon G, Ortega P, Grube SM (1973) Instantaneous and sudden deaths. Clinical and pathological differentiation in coronary artery disease. J Am Med Ass 225:1319–1328

    Google Scholar 

  5. Patterson E, Holland K, Eller BT, Lucchesi BR (1982) Ventricular fibrillation resulting from eischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. Am J Cardiol 50:1414–1423

    PubMed  Google Scholar 

  6. Johnston KM, MacLeod BA, Walker MJA (1983) Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size. Br J Pharmac 78:29–37

    Google Scholar 

  7. Romson JL, Haack DW, Abrams GD, Lucchesi (1981) Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog. Circulation 64:906–914

    PubMed  Google Scholar 

  8. Kettler D, Braun U, Cott LA, Heiss HW, Hensel I, Martel J, Paschen K, Bretschneider HJ (1971) Kombination von Piritramid und N2O — ein neues Narkoseverfahren. Teil I: Tierexperimentelle Untersuchungen. Z prakt Anästh 6:329–338

    Google Scholar 

  9. Romson JL, Haack DW, Lucchesi BR (1980) Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents. Thromb Res 17:841–853

    PubMed  Google Scholar 

  10. Romson JL, Bush LR, Haack DW, Lucchesi BR (1980) The beneficial effect of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog. J Pharmacol Exp Ther 215:271–278

    PubMed  Google Scholar 

  11. Hosko MJ, Gross GJ, Warltier DC (1977) Technique for precise, graded arterial stenosis and occlusion. Basic Res Cardiol 72:651–659

    PubMed  Google Scholar 

  12. Elsinga WE, Skinner DB (1975) Hemodynamic characteristics of critical stenosis in canine coronary arteries. J Thorac Cardiovasc Surg 69:217–222

    PubMed  Google Scholar 

  13. Sandritter W, Jestädt R (1958) Triphenyltetrazoliumchlorid (TTC) als Reduktionsindikator zur makroskopischen Diagnose des frischen Herzinfarktes. Verh dtsch Ges Pathol 41:165–170

    Google Scholar 

  14. Schaper J, Schaper W (1983) Reperfusion of ischemic myocardium: ultrastructural and histochemical aspects. J Am Coll Cardiol 1:1037–1046

    PubMed  Google Scholar 

  15. Miura M, Thomas R, Ganz W, Sokol T, Shell WE, Toshimitsu T, Kwan AC, Singh BN (1979) The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation 59:1148–1157

    PubMed  Google Scholar 

  16. Liberthson RR, Nagel EH, Hirshman JC, Nussenfeld SR, Blackbourne BD, Davis JH (1974) Pathophysiologic observation in prehospital ventricular fibrillation and sudden cardiac death. Circulation 49:790–798

    PubMed  Google Scholar 

  17. Reichenbach DD, Moss NS, Meyer E (1977) Pathology of the heart in sudden cardiac death. Am J Cardiol 39:865–872

    PubMed  Google Scholar 

  18. Ruskin JN, DiMarco JP, Garan H (1980) Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med 303:607–613

    PubMed  Google Scholar 

  19. Lown B, Kosowsky BD, Klein MD (1969) Pathogenesis, prevention, and treatment of arrhythmias in myocardial infarction. Circulation 39/40 (Suppl IV):261–267

    Google Scholar 

  20. Holland K, Patterson E, Lucchesi BR (1983) Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. Am Heart J 105:711–717

    PubMed  Google Scholar 

  21. Chiba S, Malik KU (1980) Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the action of prostaglyndin E2. J Pharmacol Exp Ther 213:261–266

    PubMed  Google Scholar 

  22. Hintze TH, Kaley G (1984) Ventricular receptors activated following myocardial prostaglandin synthesis initiate reflex hypotension, reduction in heart rate, and redistribution of cardiac output in the dog. Circ Res 54:239–247

    PubMed  Google Scholar 

  23. Kowey PR, Verrier RL, Lown B (1982) Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart. Eur J Pharmacol 80:83–91

    PubMed  Google Scholar 

  24. Jones CE, Beck LY, DuPont E, Barner GE (1978) Effects of coronary ligation on the chronically sympathectomized dog ventricle. Am J Physiol 235:H429-H434

    PubMed  Google Scholar 

  25. Jennings RB, Reimer KA (1983) Factors involved in salvaging ischemic myocardium: effct of reperfusion or arterial blood. Circulation 68(Suppl I):125–136

    Google Scholar 

  26. Manning AS, Hearse DJ (1984) Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 16:497–518

    PubMed  Google Scholar 

  27. Jugdutt BI (1981) Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size. Prostagland Med 7:431–455

    Google Scholar 

  28. Lefer AM, Ogletree ML, Smith JB, Silver MJ, Nicolaou KC, Barnette WE, Gasic GP (1978) Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science 200:52–54

    PubMed  Google Scholar 

  29. Jørgensen L, Haerem JW, Chandler AB, Borchgrevink CF (1968) The pathology of acute coronary death. Acta Anaesth Scand 29(Suppl):139–199

    Google Scholar 

  30. Jørgensen L (1969) The role of platelet embolism from crumbling thrombi and of platelet aggregates arising in flowing blood. In: Sherry S, Brinkhous KM, Genton E, Stengle JM (eds) Thrombosis. National Academy of Sciences, Washington, pp 506–533

    Google Scholar 

  31. Haerem JW (1971) Sudden coronary death: the occurrence of platelet aggregates in the epicardial arteries in man. Atherosclerosis 14:417–432

    PubMed  Google Scholar 

  32. Haerem JW (1974) Platelet aggregates and mural microthrombi in the early stages of acute, fatal coronary disease. Thromb Res 5:243–249

    PubMed  Google Scholar 

  33. Fiedler VB, Mardin M (1985) Prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments. Arch int Pharmacodyn (in press)

  34. Coker SJ, Parratt JR, Ledingham IMcA, Zeitlin IJ (1981) Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature New Biol 291:323–324

    Google Scholar 

Download references

Author information

Author notes

  1. V. B. Fiedler

    Present address: Department of Pharmacology, Bayer AG, P.O. Box 101709, D-5600, Wuppertal 1 (Elberfeld), West Germany

Authors and Affiliations

  1. Department of Pharmacology, Bayer AG, P.O. Box 101709, D-5600, Wuppertal 1 (Elberfeld), West Germany

    M. Mardin

Authors
  1. V. B. Fiedler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Mardin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fiedler, V.B., Mardin, M. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death. Basic Res Cardiol 81, 40–53 (1986). https://doi.org/10.1007/BF01907426

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01907426

Key words

Search

Navigation